Phenotypic and Molecular Characterization of CD103+ CD4 + T Cells in Bronchoalveolar Lavage from Patients with Interstitial Lung Diseases

Cytometry Part B - Clinical Cytometry

Volumn 54, Issue 1, 2003, Pages 19-27

  Braun, Ruedi K ^a   Foerster, Martin ^b   Grahmann, P Reinhard ^b   Haefner, Daniela ^b   Workalemahu, Grefachew ^b   Kroegel, Claus ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

CD103; CD4+ T lymphocytes; Flow cytometry; Intraepithelial lymphocytes

Indexed keywords

CD103 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PADGEM PROTEIN; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 1; ALPHA E INTEGRINS; ALPHA INTEGRIN; CYTOKINE; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CYTOKINE PRODUCTION; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, CD45; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA CHAINS; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 1542286497     PISSN: 15524949     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.b.10021     Document Type: Article

References (35)

1. Poussier P, Julius M. Intestinal intraepithelial lymphocytes: the plot thickens. J Exp Med 1994;180:1185-1189.
2. Sim GK. Intraepithelial lymphocytes and the immune system. Adv Immunol 1995;58:297-343.
3. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol 1993;11:637-685.
4. Allison JP, Havran WL. The immunobiology of T cells with invariant gamma delta antigen receptors. Annu Rev Immunol 1991;9:679-705.
5. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, Brenner MB. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994;372:190-193.
6. Erle DJ, Brown T, Christian D, Aris R. Lung epithelial lining fluid T cell subsets defined by distinct patterns of beta 7 and beta 1 integrin expression. Am J Respir Cell Mol Biol 1994;10:237-244.
7. Erle DJ, Pabst R. Intraepithelial lymphocytes in the lung: a neglected lymphocyte population. Am J Respir Cell Mol Biol 2000;22:398-400.
8. Rihs S, Walker C, Virchow JC, Boer C, Kroegel C, Giri SN, Braun RK. Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta. Am J Respir Cell Mol Biol 1996;15:600-610.
9. Lohmeyer J, Friedrich J, Grimminger F, Maus U, Tenter R, Morr H, Velcovsky HG, Seeger W, Rosseau S. Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol 1999;116:340-346.
10. Hemler ME, Jacobson JG, Brenner MB, Mann D, Strominger JL. VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol 1985;15:502-508.
11. Schon MP, Arya A, Murphy EA, Adams CM, Strauch UG, Agace WW, Marsal J, Donohue JP, Her H, Beier DR, Olson S, Lefrancois L, Brenner MB, Grusby MJ, Parker CM. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 1999;162:6641-6649.
12. Feng Y, Wang D, Yuan R, Parker CM, Farber DL, Hadley GA. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med 2002;196:877-886.
13. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
14. Respiratory health hazards in agriculture. Am J Respir Crit Care Med 1998;158:S1-S76.
15. Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone ML. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 1996;9:2513-2516.
16. Morgan WKC. The pneumoconiosis. In: Grassi, C, Fishmann, AP, editors. Pulmonary disease. New York: McGraw-Hill; 1999. p 273-282.
17. Sobin LH, Wittekind C. TNM classification of malignant tumors. New York: John Wiley & Sons; 2002.
18. Kilshaw PJ, Murant SJ. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol 1990;20:2201-2207.
19. Marrack P, Bender J, Hildeman D, Jordan M, Mitchell T, Murakami M, Sakamoto A, Schaefer BC, Swanson B, Kappler J. Homeostasis of alpha beta TCR+ T cells. Nat Immunol 2000;1:107-111.
20. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002;2:251-262.
21. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
22. Hall SR, Heffernan BM, Thompson NT, Rowan WC. CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses. Eur J Immunol 1999;29:2098-2106.
23. Eck SC, Chang D, Wells AD, Turka LA. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 1997;64:1497-1499.
24. Howland KC, Ausubel LJ, London CA, Abbas AK. The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol 2000;164:4465-4470.
25. Lefrancois L, Barrett TA, Havran WL, Puddington L. Developmental expression of the alpha IEL beta 7 integrin on T cell receptor gamma delta and T cell receptor alpha beta T cells. Eur J Immunol 1994;24:635-640.
26. Begue B, Sarnacki S, Le Deist F, Buc H, Gagnon J, Meo T, Cerf-Bensussan N. HML-1, a novel integrin made of the beta 7 chain and of a distinctive alpha chain, exerts an accessory function in the activation of human IEL via the CD3-TCR pathway. Adv Exp Med Biol 1995;371A:67-75.
27. Sarnacki S, Begue B, Buc H, Le Deist F, Cerf-Bensussan N. Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur J Immunol 1992;22:2887-2892.
28. Russell GJ, Parker CM, Sood A, Mizoguchi E, Ebert EC, Bhan AK, Brenner MB. P126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J Immunol 1996;157:3366-3374.
29. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 1999;162:6572-6579.
30. -/- mice. J Immunol 1999;162:4975-4982.
31. Schon MP, Schon M, Warren HB, Donohue JP, Parker CM. Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. J Immunol 2000;165:6583-6589.
32. Hintzen RQ, de Jong R, Lens SM, van Lier RA. CD27: marker and mediator of T-cell activation? Immunol Today 1994;15:307-311.
33. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof Garde SR, Klein MR, van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997;186:1407-1418.
34. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J Exp Med 2000;191:1241-1246.
35. Slifka MK, Whitton JL. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 2000;164:208-216.